lifestyle.d-h.st

Author: enVVeno Medical Corporation

enVVeno Medical Receives First-Ever FDA IDE Approval for a U.S. Pivotal Study of a Non-Surgical Replacement Venous Valve

April 29, 2026
enVVeno Medical Reports Full Year 2025 Financial Results and Highlights Strategic Advancement of enVVe(R) System

March 27, 2026
enVVeno Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement

February 10, 2026
enVVeno Medical Announces Reverse Stock Split

January 15, 2026